Kauffman Fellows@KauffmanFellows

2 years ago

💸 Entrepreneurs, pull those decks out of the dusty drawer. VCs expect a complete reversal of the 2023 dry season, but, as @_fredrik (@creandum) says, 2024 is the year of truth. There will be an increased focus on retention and value. Download the report: https://t.co/JBxuRdDTC6 https://t.co/1SxjHG4tkR

Venture capital dry powder has nowhere to go As the start-up downturn continues, it has become difficult to persuade investors to part with their money via @FT #VC https://t.co/Yn3NWdqYwF

STAT@statnews

2 years ago

Venture-backed biopharma companies raised $6.8 billion in the first three months of the year — the largest amount raised since the first half of 2022. https://t.co/6sMg2Pm1VE